Carfentanil is a β-arrestin-biased agonist at the μ opioid receptor.

Nokomis Ramos-GonzalezSam GroomKaty J SutcliffeSukhvinder BancroftChris P BaileyRichard B SessionsGraeme Henderson Eamonn Kelly

Published in: British journal of pharmacology (2023)

Carfentanil is a β-arrestin-biased opioid drug at the μ opioid receptor. It remains to be seen how such bias influences the in vivo effects of carfentanil relative to other fentanyls.

Keyphrases

chronic pain
pain management
binding protein
drug induced
electronic health record